GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanosonics Ltd (ASX:NAN) » Definitions » Current Deferred Taxes Liabilities

Nanosonics (ASX:NAN) Current Deferred Taxes Liabilities : A$1.1 Mil (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Nanosonics Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Nanosonics's current deferred tax liabilities for the quarter that ended in Dec. 2023 was A$1.1 Mil.

Nanosonics Current Deferred Taxes Liabilities Historical Data

The historical data trend for Nanosonics's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosonics Current Deferred Taxes Liabilities Chart

Nanosonics Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Current Deferred Taxes Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.08 0.09 0.72 0.76 2.13

Nanosonics Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.76 1.00 2.13 1.12

Nanosonics Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Nanosonics's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanosonics (ASX:NAN) Business Description

Traded in Other Exchanges
Address
7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113
Nanosonics is a single-product firm and its trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low temperature sonically activated hydrogen peroxide mist that is suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection across patients. Nanosonics' revenue is made up of capital sales of trophon units, ongoing consumables sales, and service revenue. At June 2022, there were 29,850 trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, roughly 44% in the U.S. to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in Asia-Pacific.

Nanosonics (ASX:NAN) Headlines